Jonathan Wofford is responsible for the continued development of Biotherapy (formerly Transtem) software. He has extensive background in the fields of hematopoietic cell transplant and cellular therapy, applying statistical theory to evaluate the safety, purity, and potency of these therapies. Prior to WellSky, he spent over a decade as the bioinformatics lead for the St. Louis Cord Blood Bank and was a member of the transplant committee for St. Louis University Medical Center. His work has been presented at published at leading industry conferences and journals. Jonathan was honored by the Center for International Blood and Marrow Transplant Research (CIBMTR) for outstanding clinical research and presented to members of the United States Congress to advance the use of adult stem cells and to secure funding for the National Marrow Donor Program (NMDP). He’s served on industry committees working to standardize data collection and the evaluation of transplant protocols and patient outcomes. Prior to entering the field of stem cell medicine, he designed disease management programs and analytical models for a major health management organization.